Financial Summary (All financials)
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
Revenues | 280.0 | 206.7 | 150.8 | 104.7 | 63.5 |
Revenue growth | 35.5% | 37.0% | 44.0% | 64.8% | |
Cost of goods sold | 62.3 | 41.8 | 28.5 | 20.0 | 10.7 |
Gross profit | 217.8 | 164.9 | 122.4 | 84.7 | 52.8 |
Gross margin | 77.8% | 79.8% | 81.1% | 80.9% | 83.1% |
Sales and marketing | 130.8 | 97.0 | 60.9 | 44.1 | 35.0 |
Research and development | 121.2 | 79.6 | 41.1 | 29.7 | 25.9 |
General and administrative | 55.6 | 56.7 | 34.5 | 17.8 | 18.8 |
EBITA | -78.2 | -62.5 | -12.6 | -5.4 | -26.9 |
EBITA margin | -27.9% | -30.2% | -8.3% | -5.2% | -42.3% |
Amortization of intangibles | 11.6 | 5.9 | 1.6 | 1.5 | |
EBIT | -89.8 | -68.4 | -14.2 | -6.9 | -26.9 |
EBIT margin | -32.1% | -33.1% | -9.4% | -6.6% | -42.3% |
Pre-tax income | -84.7 | -67.6 | -12.1 | -3.8 | -25.5 |
Income taxes | 5.4 | -3.4 | -2.7 | 1.6 | 0.5 |
Tax rate | | 5.1% | 22.6% | | |
Net income | -90.2 | -64.2 | -9.4 | -5.4 | -26.0 |
Net margin | -32.2% | -31.1% | -6.2% | -5.2% | -40.9% |
|
Diluted EPS | ($0.91) | ($0.68) | ($0.20) | ($0.20) | |
Shares outstanding (diluted) | 99.2 | 94.8 | 46.5 | 27.1 | |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|